Medical Care
Global Retroviral Vectors Market Research Report 2024
- Mar 11, 25
- ID: 6290
- Pages: 83
- Figures: 84
- Views: 1
The global market for Retroviral Vectors was valued at US$ 412 million in the year 2023 and is projected to reach a revised size of US$ 797 million by 2030, growing at a CAGR of 8.7% during the forecast period.
Retroviral vectors transduce a wide range of hard-to-infect dividing cells and integrate into the host genome, which makes them ideal for long-term, stable expression of your transgene.As the number and variety of planned CAR-T and gene therapy trials increases with each year, the need for commercial-grade retrovirus also continues to grow.
North American market for Retroviral Vectors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Retroviral Vectors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Retroviral Vectors in Gene Therapy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Retroviral Vectors include Merck KGaA, Biovian, Esco Lifesciences Group, ABL, Inc., Genezen, AGC Inc. Group (AGC Biologics), Thermo Fisher Scientific Inc., Creative Biogene, CD Bioparticles, Charles River Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Retroviral Vectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Retroviral Vectors.
The Retroviral Vectors market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Retroviral Vectors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Retroviral Vectors companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck KGaA
Biovian
Esco Lifesciences Group
ABL, Inc.
Genezen
AGC Inc. Group (AGC Biologics)
Thermo Fisher Scientific Inc.
Creative Biogene
CD Bioparticles
Charles River Laboratories
Avid Bioservices, Inc.
Segment by Type
Research / Preclinical Grade
Clinical Grade
Commercial Grade
Segment by Application
Gene Therapy
Vaccine Development
Cell Therapy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Retroviral Vectors company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Retroviral vectors transduce a wide range of hard-to-infect dividing cells and integrate into the host genome, which makes them ideal for long-term, stable expression of your transgene.As the number and variety of planned CAR-T and gene therapy trials increases with each year, the need for commercial-grade retrovirus also continues to grow.
North American market for Retroviral Vectors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Retroviral Vectors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Retroviral Vectors in Gene Therapy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Retroviral Vectors include Merck KGaA, Biovian, Esco Lifesciences Group, ABL, Inc., Genezen, AGC Inc. Group (AGC Biologics), Thermo Fisher Scientific Inc., Creative Biogene, CD Bioparticles, Charles River Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Retroviral Vectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Retroviral Vectors.
The Retroviral Vectors market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Retroviral Vectors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Retroviral Vectors companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck KGaA
Biovian
Esco Lifesciences Group
ABL, Inc.
Genezen
AGC Inc. Group (AGC Biologics)
Thermo Fisher Scientific Inc.
Creative Biogene
CD Bioparticles
Charles River Laboratories
Avid Bioservices, Inc.
Segment by Type
Research / Preclinical Grade
Clinical Grade
Commercial Grade
Segment by Application
Gene Therapy
Vaccine Development
Cell Therapy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Retroviral Vectors company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retroviral Vectors Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Research / Preclinical Grade
1.2.3 Clinical Grade
1.2.4 Commercial Grade
1.3 Market by Application
1.3.1 Global Retroviral Vectors Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Gene Therapy
1.3.3 Vaccine Development
1.3.4 Cell Therapy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Retroviral Vectors Market Perspective (2019-2030)
2.2 Global Retroviral Vectors Growth Trends by Region
2.2.1 Global Retroviral Vectors Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Retroviral Vectors Historic Market Size by Region (2019-2024)
2.2.3 Retroviral Vectors Forecasted Market Size by Region (2025-2030)
2.3 Retroviral Vectors Market Dynamics
2.3.1 Retroviral Vectors Industry Trends
2.3.2 Retroviral Vectors Market Drivers
2.3.3 Retroviral Vectors Market Challenges
2.3.4 Retroviral Vectors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Retroviral Vectors Players by Revenue
3.1.1 Global Top Retroviral Vectors Players by Revenue (2019-2024)
3.1.2 Global Retroviral Vectors Revenue Market Share by Players (2019-2024)
3.2 Global Retroviral Vectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Retroviral Vectors Revenue
3.4 Global Retroviral Vectors Market Concentration Ratio
3.4.1 Global Retroviral Vectors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retroviral Vectors Revenue in 2023
3.5 Global Key Players of Retroviral Vectors Head office and Area Served
3.6 Global Key Players of Retroviral Vectors, Product and Application
3.7 Global Key Players of Retroviral Vectors, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Retroviral Vectors Breakdown Data by Type
4.1 Global Retroviral Vectors Historic Market Size by Type (2019-2024)
4.2 Global Retroviral Vectors Forecasted Market Size by Type (2025-2030)
5 Retroviral Vectors Breakdown Data by Application
5.1 Global Retroviral Vectors Historic Market Size by Application (2019-2024)
5.2 Global Retroviral Vectors Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Retroviral Vectors Market Size (2019-2030)
6.2 North America Retroviral Vectors Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Retroviral Vectors Market Size by Country (2019-2024)
6.4 North America Retroviral Vectors Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Retroviral Vectors Market Size (2019-2030)
7.2 Europe Retroviral Vectors Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Retroviral Vectors Market Size by Country (2019-2024)
7.4 Europe Retroviral Vectors Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Retroviral Vectors Market Size (2019-2030)
8.2 Asia-Pacific Retroviral Vectors Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Retroviral Vectors Market Size by Region (2019-2024)
8.4 Asia-Pacific Retroviral Vectors Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Retroviral Vectors Market Size (2019-2030)
9.2 Latin America Retroviral Vectors Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Retroviral Vectors Market Size by Country (2019-2024)
9.4 Latin America Retroviral Vectors Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Retroviral Vectors Market Size (2019-2030)
10.2 Middle East & Africa Retroviral Vectors Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Retroviral Vectors Market Size by Country (2019-2024)
10.4 Middle East & Africa Retroviral Vectors Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Retroviral Vectors Introduction
11.1.4 Merck KGaA Revenue in Retroviral Vectors Business (2019-2024)
11.1.5 Merck KGaA Recent Development
11.2 Biovian
11.2.1 Biovian Company Details
11.2.2 Biovian Business Overview
11.2.3 Biovian Retroviral Vectors Introduction
11.2.4 Biovian Revenue in Retroviral Vectors Business (2019-2024)
11.2.5 Biovian Recent Development
11.3 Esco Lifesciences Group
11.3.1 Esco Lifesciences Group Company Details
11.3.2 Esco Lifesciences Group Business Overview
11.3.3 Esco Lifesciences Group Retroviral Vectors Introduction
11.3.4 Esco Lifesciences Group Revenue in Retroviral Vectors Business (2019-2024)
11.3.5 Esco Lifesciences Group Recent Development
11.4 ABL, Inc.
11.4.1 ABL, Inc. Company Details
11.4.2 ABL, Inc. Business Overview
11.4.3 ABL, Inc. Retroviral Vectors Introduction
11.4.4 ABL, Inc. Revenue in Retroviral Vectors Business (2019-2024)
11.4.5 ABL, Inc. Recent Development
11.5 Genezen
11.5.1 Genezen Company Details
11.5.2 Genezen Business Overview
11.5.3 Genezen Retroviral Vectors Introduction
11.5.4 Genezen Revenue in Retroviral Vectors Business (2019-2024)
11.5.5 Genezen Recent Development
11.6 AGC Inc. Group (AGC Biologics)
11.6.1 AGC Inc. Group (AGC Biologics) Company Details
11.6.2 AGC Inc. Group (AGC Biologics) Business Overview
11.6.3 AGC Inc. Group (AGC Biologics) Retroviral Vectors Introduction
11.6.4 AGC Inc. Group (AGC Biologics) Revenue in Retroviral Vectors Business (2019-2024)
11.6.5 AGC Inc. Group (AGC Biologics) Recent Development
11.7 Thermo Fisher Scientific Inc.
11.7.1 Thermo Fisher Scientific Inc. Company Details
11.7.2 Thermo Fisher Scientific Inc. Business Overview
11.7.3 Thermo Fisher Scientific Inc. Retroviral Vectors Introduction
11.7.4 Thermo Fisher Scientific Inc. Revenue in Retroviral Vectors Business (2019-2024)
11.7.5 Thermo Fisher Scientific Inc. Recent Development
11.8 Creative Biogene
11.8.1 Creative Biogene Company Details
11.8.2 Creative Biogene Business Overview
11.8.3 Creative Biogene Retroviral Vectors Introduction
11.8.4 Creative Biogene Revenue in Retroviral Vectors Business (2019-2024)
11.8.5 Creative Biogene Recent Development
11.9 CD Bioparticles
11.9.1 CD Bioparticles Company Details
11.9.2 CD Bioparticles Business Overview
11.9.3 CD Bioparticles Retroviral Vectors Introduction
11.9.4 CD Bioparticles Revenue in Retroviral Vectors Business (2019-2024)
11.9.5 CD Bioparticles Recent Development
11.10 Charles River Laboratories
11.10.1 Charles River Laboratories Company Details
11.10.2 Charles River Laboratories Business Overview
11.10.3 Charles River Laboratories Retroviral Vectors Introduction
11.10.4 Charles River Laboratories Revenue in Retroviral Vectors Business (2019-2024)
11.10.5 Charles River Laboratories Recent Development
11.11 Avid Bioservices, Inc.
11.11.1 Avid Bioservices, Inc. Company Details
11.11.2 Avid Bioservices, Inc. Business Overview
11.11.3 Avid Bioservices, Inc. Retroviral Vectors Introduction
11.11.4 Avid Bioservices, Inc. Revenue in Retroviral Vectors Business (2019-2024)
11.11.5 Avid Bioservices, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retroviral Vectors Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Research / Preclinical Grade
1.2.3 Clinical Grade
1.2.4 Commercial Grade
1.3 Market by Application
1.3.1 Global Retroviral Vectors Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Gene Therapy
1.3.3 Vaccine Development
1.3.4 Cell Therapy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Retroviral Vectors Market Perspective (2019-2030)
2.2 Global Retroviral Vectors Growth Trends by Region
2.2.1 Global Retroviral Vectors Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Retroviral Vectors Historic Market Size by Region (2019-2024)
2.2.3 Retroviral Vectors Forecasted Market Size by Region (2025-2030)
2.3 Retroviral Vectors Market Dynamics
2.3.1 Retroviral Vectors Industry Trends
2.3.2 Retroviral Vectors Market Drivers
2.3.3 Retroviral Vectors Market Challenges
2.3.4 Retroviral Vectors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Retroviral Vectors Players by Revenue
3.1.1 Global Top Retroviral Vectors Players by Revenue (2019-2024)
3.1.2 Global Retroviral Vectors Revenue Market Share by Players (2019-2024)
3.2 Global Retroviral Vectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Retroviral Vectors Revenue
3.4 Global Retroviral Vectors Market Concentration Ratio
3.4.1 Global Retroviral Vectors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retroviral Vectors Revenue in 2023
3.5 Global Key Players of Retroviral Vectors Head office and Area Served
3.6 Global Key Players of Retroviral Vectors, Product and Application
3.7 Global Key Players of Retroviral Vectors, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Retroviral Vectors Breakdown Data by Type
4.1 Global Retroviral Vectors Historic Market Size by Type (2019-2024)
4.2 Global Retroviral Vectors Forecasted Market Size by Type (2025-2030)
5 Retroviral Vectors Breakdown Data by Application
5.1 Global Retroviral Vectors Historic Market Size by Application (2019-2024)
5.2 Global Retroviral Vectors Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Retroviral Vectors Market Size (2019-2030)
6.2 North America Retroviral Vectors Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Retroviral Vectors Market Size by Country (2019-2024)
6.4 North America Retroviral Vectors Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Retroviral Vectors Market Size (2019-2030)
7.2 Europe Retroviral Vectors Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Retroviral Vectors Market Size by Country (2019-2024)
7.4 Europe Retroviral Vectors Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Retroviral Vectors Market Size (2019-2030)
8.2 Asia-Pacific Retroviral Vectors Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Retroviral Vectors Market Size by Region (2019-2024)
8.4 Asia-Pacific Retroviral Vectors Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Retroviral Vectors Market Size (2019-2030)
9.2 Latin America Retroviral Vectors Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Retroviral Vectors Market Size by Country (2019-2024)
9.4 Latin America Retroviral Vectors Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Retroviral Vectors Market Size (2019-2030)
10.2 Middle East & Africa Retroviral Vectors Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Retroviral Vectors Market Size by Country (2019-2024)
10.4 Middle East & Africa Retroviral Vectors Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Retroviral Vectors Introduction
11.1.4 Merck KGaA Revenue in Retroviral Vectors Business (2019-2024)
11.1.5 Merck KGaA Recent Development
11.2 Biovian
11.2.1 Biovian Company Details
11.2.2 Biovian Business Overview
11.2.3 Biovian Retroviral Vectors Introduction
11.2.4 Biovian Revenue in Retroviral Vectors Business (2019-2024)
11.2.5 Biovian Recent Development
11.3 Esco Lifesciences Group
11.3.1 Esco Lifesciences Group Company Details
11.3.2 Esco Lifesciences Group Business Overview
11.3.3 Esco Lifesciences Group Retroviral Vectors Introduction
11.3.4 Esco Lifesciences Group Revenue in Retroviral Vectors Business (2019-2024)
11.3.5 Esco Lifesciences Group Recent Development
11.4 ABL, Inc.
11.4.1 ABL, Inc. Company Details
11.4.2 ABL, Inc. Business Overview
11.4.3 ABL, Inc. Retroviral Vectors Introduction
11.4.4 ABL, Inc. Revenue in Retroviral Vectors Business (2019-2024)
11.4.5 ABL, Inc. Recent Development
11.5 Genezen
11.5.1 Genezen Company Details
11.5.2 Genezen Business Overview
11.5.3 Genezen Retroviral Vectors Introduction
11.5.4 Genezen Revenue in Retroviral Vectors Business (2019-2024)
11.5.5 Genezen Recent Development
11.6 AGC Inc. Group (AGC Biologics)
11.6.1 AGC Inc. Group (AGC Biologics) Company Details
11.6.2 AGC Inc. Group (AGC Biologics) Business Overview
11.6.3 AGC Inc. Group (AGC Biologics) Retroviral Vectors Introduction
11.6.4 AGC Inc. Group (AGC Biologics) Revenue in Retroviral Vectors Business (2019-2024)
11.6.5 AGC Inc. Group (AGC Biologics) Recent Development
11.7 Thermo Fisher Scientific Inc.
11.7.1 Thermo Fisher Scientific Inc. Company Details
11.7.2 Thermo Fisher Scientific Inc. Business Overview
11.7.3 Thermo Fisher Scientific Inc. Retroviral Vectors Introduction
11.7.4 Thermo Fisher Scientific Inc. Revenue in Retroviral Vectors Business (2019-2024)
11.7.5 Thermo Fisher Scientific Inc. Recent Development
11.8 Creative Biogene
11.8.1 Creative Biogene Company Details
11.8.2 Creative Biogene Business Overview
11.8.3 Creative Biogene Retroviral Vectors Introduction
11.8.4 Creative Biogene Revenue in Retroviral Vectors Business (2019-2024)
11.8.5 Creative Biogene Recent Development
11.9 CD Bioparticles
11.9.1 CD Bioparticles Company Details
11.9.2 CD Bioparticles Business Overview
11.9.3 CD Bioparticles Retroviral Vectors Introduction
11.9.4 CD Bioparticles Revenue in Retroviral Vectors Business (2019-2024)
11.9.5 CD Bioparticles Recent Development
11.10 Charles River Laboratories
11.10.1 Charles River Laboratories Company Details
11.10.2 Charles River Laboratories Business Overview
11.10.3 Charles River Laboratories Retroviral Vectors Introduction
11.10.4 Charles River Laboratories Revenue in Retroviral Vectors Business (2019-2024)
11.10.5 Charles River Laboratories Recent Development
11.11 Avid Bioservices, Inc.
11.11.1 Avid Bioservices, Inc. Company Details
11.11.2 Avid Bioservices, Inc. Business Overview
11.11.3 Avid Bioservices, Inc. Retroviral Vectors Introduction
11.11.4 Avid Bioservices, Inc. Revenue in Retroviral Vectors Business (2019-2024)
11.11.5 Avid Bioservices, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Retroviral Vectors Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Research / Preclinical Grade
Table 3. Key Players of Clinical Grade
Table 4. Key Players of Commercial Grade
Table 5. Global Retroviral Vectors Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Retroviral Vectors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Retroviral Vectors Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Retroviral Vectors Market Share by Region (2019-2024)
Table 9. Global Retroviral Vectors Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Retroviral Vectors Market Share by Region (2025-2030)
Table 11. Retroviral Vectors Market Trends
Table 12. Retroviral Vectors Market Drivers
Table 13. Retroviral Vectors Market Challenges
Table 14. Retroviral Vectors Market Restraints
Table 15. Global Retroviral Vectors Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Retroviral Vectors Market Share by Players (2019-2024)
Table 17. Global Top Retroviral Vectors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retroviral Vectors as of 2023)
Table 18. Ranking of Global Top Retroviral Vectors Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Retroviral Vectors Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Retroviral Vectors, Headquarters and Area Served
Table 21. Global Key Players of Retroviral Vectors, Product and Application
Table 22. Global Key Players of Retroviral Vectors, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Retroviral Vectors Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Retroviral Vectors Revenue Market Share by Type (2019-2024)
Table 26. Global Retroviral Vectors Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Retroviral Vectors Revenue Market Share by Type (2025-2030)
Table 28. Global Retroviral Vectors Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Retroviral Vectors Revenue Market Share by Application (2019-2024)
Table 30. Global Retroviral Vectors Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Retroviral Vectors Revenue Market Share by Application (2025-2030)
Table 32. North America Retroviral Vectors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Retroviral Vectors Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Retroviral Vectors Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Retroviral Vectors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Retroviral Vectors Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Retroviral Vectors Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Retroviral Vectors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Retroviral Vectors Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Retroviral Vectors Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Retroviral Vectors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Retroviral Vectors Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Retroviral Vectors Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Retroviral Vectors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Retroviral Vectors Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Retroviral Vectors Market Size by Country (2025-2030) & (US$ Million)
Table 47. Merck KGaA Company Details
Table 48. Merck KGaA Business Overview
Table 49. Merck KGaA Retroviral Vectors Product
Table 50. Merck KGaA Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)
Table 51. Merck KGaA Recent Development
Table 52. Biovian Company Details
Table 53. Biovian Business Overview
Table 54. Biovian Retroviral Vectors Product
Table 55. Biovian Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)
Table 56. Biovian Recent Development
Table 57. Esco Lifesciences Group Company Details
Table 58. Esco Lifesciences Group Business Overview
Table 59. Esco Lifesciences Group Retroviral Vectors Product
Table 60. Esco Lifesciences Group Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)
Table 61. Esco Lifesciences Group Recent Development
Table 62. ABL, Inc. Company Details
Table 63. ABL, Inc. Business Overview
Table 64. ABL, Inc. Retroviral Vectors Product
Table 65. ABL, Inc. Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)
Table 66. ABL, Inc. Recent Development
Table 67. Genezen Company Details
Table 68. Genezen Business Overview
Table 69. Genezen Retroviral Vectors Product
Table 70. Genezen Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)
Table 71. Genezen Recent Development
Table 72. AGC Inc. Group (AGC Biologics) Company Details
Table 73. AGC Inc. Group (AGC Biologics) Business Overview
Table 74. AGC Inc. Group (AGC Biologics) Retroviral Vectors Product
Table 75. AGC Inc. Group (AGC Biologics) Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)
Table 76. AGC Inc. Group (AGC Biologics) Recent Development
Table 77. Thermo Fisher Scientific Inc. Company Details
Table 78. Thermo Fisher Scientific Inc. Business Overview
Table 79. Thermo Fisher Scientific Inc. Retroviral Vectors Product
Table 80. Thermo Fisher Scientific Inc. Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)
Table 81. Thermo Fisher Scientific Inc. Recent Development
Table 82. Creative Biogene Company Details
Table 83. Creative Biogene Business Overview
Table 84. Creative Biogene Retroviral Vectors Product
Table 85. Creative Biogene Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)
Table 86. Creative Biogene Recent Development
Table 87. CD Bioparticles Company Details
Table 88. CD Bioparticles Business Overview
Table 89. CD Bioparticles Retroviral Vectors Product
Table 90. CD Bioparticles Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)
Table 91. CD Bioparticles Recent Development
Table 92. Charles River Laboratories Company Details
Table 93. Charles River Laboratories Business Overview
Table 94. Charles River Laboratories Retroviral Vectors Product
Table 95. Charles River Laboratories Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)
Table 96. Charles River Laboratories Recent Development
Table 97. Avid Bioservices, Inc. Company Details
Table 98. Avid Bioservices, Inc. Business Overview
Table 99. Avid Bioservices, Inc. Retroviral Vectors Product
Table 100. Avid Bioservices, Inc. Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)
Table 101. Avid Bioservices, Inc. Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 105. Authors List of This Report
List of Figures
Figure 1. Retroviral Vectors Picture
Figure 2. Global Retroviral Vectors Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Retroviral Vectors Market Share by Type: 2023 VS 2030
Figure 4. Research / Preclinical Grade Features
Figure 5. Clinical Grade Features
Figure 6. Commercial Grade Features
Figure 7. Global Retroviral Vectors Market Size by Application (2024-2030) & (US$ Million)
Figure 8. Global Retroviral Vectors Market Share by Application: 2023 VS 2030
Figure 9. Gene Therapy Case Studies
Figure 10. Vaccine Development Case Studies
Figure 11. Cell Therapy Case Studies
Figure 12. Retroviral Vectors Report Years Considered
Figure 13. Global Retroviral Vectors Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Retroviral Vectors Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Retroviral Vectors Market Share by Region: 2023 VS 2030
Figure 16. Global Retroviral Vectors Market Share by Players in 2023
Figure 17. Global Top Retroviral Vectors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retroviral Vectors as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Retroviral Vectors Revenue in 2023
Figure 19. North America Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Retroviral Vectors Market Share by Country (2019-2030)
Figure 21. United States Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Retroviral Vectors Market Share by Country (2019-2030)
Figure 25. Germany Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Retroviral Vectors Market Share by Region (2019-2030)
Figure 33. China Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Retroviral Vectors Market Share by Country (2019-2030)
Figure 41. Mexico Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Retroviral Vectors Market Share by Country (2019-2030)
Figure 45. Turkey Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. UAE Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Merck KGaA Revenue Growth Rate in Retroviral Vectors Business (2019-2024)
Figure 49. Biovian Revenue Growth Rate in Retroviral Vectors Business (2019-2024)
Figure 50. Esco Lifesciences Group Revenue Growth Rate in Retroviral Vectors Business (2019-2024)
Figure 51. ABL, Inc. Revenue Growth Rate in Retroviral Vectors Business (2019-2024)
Figure 52. Genezen Revenue Growth Rate in Retroviral Vectors Business (2019-2024)
Figure 53. AGC Inc. Group (AGC Biologics) Revenue Growth Rate in Retroviral Vectors Business (2019-2024)
Figure 54. Thermo Fisher Scientific Inc. Revenue Growth Rate in Retroviral Vectors Business (2019-2024)
Figure 55. Creative Biogene Revenue Growth Rate in Retroviral Vectors Business (2019-2024)
Figure 56. CD Bioparticles Revenue Growth Rate in Retroviral Vectors Business (2019-2024)
Figure 57. Charles River Laboratories Revenue Growth Rate in Retroviral Vectors Business (2019-2024)
Figure 58. Avid Bioservices, Inc. Revenue Growth Rate in Retroviral Vectors Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Retroviral Vectors Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Research / Preclinical Grade
Table 3. Key Players of Clinical Grade
Table 4. Key Players of Commercial Grade
Table 5. Global Retroviral Vectors Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Retroviral Vectors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Retroviral Vectors Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Retroviral Vectors Market Share by Region (2019-2024)
Table 9. Global Retroviral Vectors Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Retroviral Vectors Market Share by Region (2025-2030)
Table 11. Retroviral Vectors Market Trends
Table 12. Retroviral Vectors Market Drivers
Table 13. Retroviral Vectors Market Challenges
Table 14. Retroviral Vectors Market Restraints
Table 15. Global Retroviral Vectors Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Retroviral Vectors Market Share by Players (2019-2024)
Table 17. Global Top Retroviral Vectors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retroviral Vectors as of 2023)
Table 18. Ranking of Global Top Retroviral Vectors Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Retroviral Vectors Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Retroviral Vectors, Headquarters and Area Served
Table 21. Global Key Players of Retroviral Vectors, Product and Application
Table 22. Global Key Players of Retroviral Vectors, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Retroviral Vectors Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Retroviral Vectors Revenue Market Share by Type (2019-2024)
Table 26. Global Retroviral Vectors Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Retroviral Vectors Revenue Market Share by Type (2025-2030)
Table 28. Global Retroviral Vectors Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Retroviral Vectors Revenue Market Share by Application (2019-2024)
Table 30. Global Retroviral Vectors Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Retroviral Vectors Revenue Market Share by Application (2025-2030)
Table 32. North America Retroviral Vectors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Retroviral Vectors Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Retroviral Vectors Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Retroviral Vectors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Retroviral Vectors Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Retroviral Vectors Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Retroviral Vectors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Retroviral Vectors Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Retroviral Vectors Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Retroviral Vectors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Retroviral Vectors Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Retroviral Vectors Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Retroviral Vectors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Retroviral Vectors Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Retroviral Vectors Market Size by Country (2025-2030) & (US$ Million)
Table 47. Merck KGaA Company Details
Table 48. Merck KGaA Business Overview
Table 49. Merck KGaA Retroviral Vectors Product
Table 50. Merck KGaA Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)
Table 51. Merck KGaA Recent Development
Table 52. Biovian Company Details
Table 53. Biovian Business Overview
Table 54. Biovian Retroviral Vectors Product
Table 55. Biovian Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)
Table 56. Biovian Recent Development
Table 57. Esco Lifesciences Group Company Details
Table 58. Esco Lifesciences Group Business Overview
Table 59. Esco Lifesciences Group Retroviral Vectors Product
Table 60. Esco Lifesciences Group Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)
Table 61. Esco Lifesciences Group Recent Development
Table 62. ABL, Inc. Company Details
Table 63. ABL, Inc. Business Overview
Table 64. ABL, Inc. Retroviral Vectors Product
Table 65. ABL, Inc. Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)
Table 66. ABL, Inc. Recent Development
Table 67. Genezen Company Details
Table 68. Genezen Business Overview
Table 69. Genezen Retroviral Vectors Product
Table 70. Genezen Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)
Table 71. Genezen Recent Development
Table 72. AGC Inc. Group (AGC Biologics) Company Details
Table 73. AGC Inc. Group (AGC Biologics) Business Overview
Table 74. AGC Inc. Group (AGC Biologics) Retroviral Vectors Product
Table 75. AGC Inc. Group (AGC Biologics) Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)
Table 76. AGC Inc. Group (AGC Biologics) Recent Development
Table 77. Thermo Fisher Scientific Inc. Company Details
Table 78. Thermo Fisher Scientific Inc. Business Overview
Table 79. Thermo Fisher Scientific Inc. Retroviral Vectors Product
Table 80. Thermo Fisher Scientific Inc. Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)
Table 81. Thermo Fisher Scientific Inc. Recent Development
Table 82. Creative Biogene Company Details
Table 83. Creative Biogene Business Overview
Table 84. Creative Biogene Retroviral Vectors Product
Table 85. Creative Biogene Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)
Table 86. Creative Biogene Recent Development
Table 87. CD Bioparticles Company Details
Table 88. CD Bioparticles Business Overview
Table 89. CD Bioparticles Retroviral Vectors Product
Table 90. CD Bioparticles Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)
Table 91. CD Bioparticles Recent Development
Table 92. Charles River Laboratories Company Details
Table 93. Charles River Laboratories Business Overview
Table 94. Charles River Laboratories Retroviral Vectors Product
Table 95. Charles River Laboratories Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)
Table 96. Charles River Laboratories Recent Development
Table 97. Avid Bioservices, Inc. Company Details
Table 98. Avid Bioservices, Inc. Business Overview
Table 99. Avid Bioservices, Inc. Retroviral Vectors Product
Table 100. Avid Bioservices, Inc. Revenue in Retroviral Vectors Business (2019-2024) & (US$ Million)
Table 101. Avid Bioservices, Inc. Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 105. Authors List of This Report
List of Figures
Figure 1. Retroviral Vectors Picture
Figure 2. Global Retroviral Vectors Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Retroviral Vectors Market Share by Type: 2023 VS 2030
Figure 4. Research / Preclinical Grade Features
Figure 5. Clinical Grade Features
Figure 6. Commercial Grade Features
Figure 7. Global Retroviral Vectors Market Size by Application (2024-2030) & (US$ Million)
Figure 8. Global Retroviral Vectors Market Share by Application: 2023 VS 2030
Figure 9. Gene Therapy Case Studies
Figure 10. Vaccine Development Case Studies
Figure 11. Cell Therapy Case Studies
Figure 12. Retroviral Vectors Report Years Considered
Figure 13. Global Retroviral Vectors Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Retroviral Vectors Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Retroviral Vectors Market Share by Region: 2023 VS 2030
Figure 16. Global Retroviral Vectors Market Share by Players in 2023
Figure 17. Global Top Retroviral Vectors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retroviral Vectors as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Retroviral Vectors Revenue in 2023
Figure 19. North America Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Retroviral Vectors Market Share by Country (2019-2030)
Figure 21. United States Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Retroviral Vectors Market Share by Country (2019-2030)
Figure 25. Germany Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Retroviral Vectors Market Share by Region (2019-2030)
Figure 33. China Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Retroviral Vectors Market Share by Country (2019-2030)
Figure 41. Mexico Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Retroviral Vectors Market Share by Country (2019-2030)
Figure 45. Turkey Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. UAE Retroviral Vectors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Merck KGaA Revenue Growth Rate in Retroviral Vectors Business (2019-2024)
Figure 49. Biovian Revenue Growth Rate in Retroviral Vectors Business (2019-2024)
Figure 50. Esco Lifesciences Group Revenue Growth Rate in Retroviral Vectors Business (2019-2024)
Figure 51. ABL, Inc. Revenue Growth Rate in Retroviral Vectors Business (2019-2024)
Figure 52. Genezen Revenue Growth Rate in Retroviral Vectors Business (2019-2024)
Figure 53. AGC Inc. Group (AGC Biologics) Revenue Growth Rate in Retroviral Vectors Business (2019-2024)
Figure 54. Thermo Fisher Scientific Inc. Revenue Growth Rate in Retroviral Vectors Business (2019-2024)
Figure 55. Creative Biogene Revenue Growth Rate in Retroviral Vectors Business (2019-2024)
Figure 56. CD Bioparticles Revenue Growth Rate in Retroviral Vectors Business (2019-2024)
Figure 57. Charles River Laboratories Revenue Growth Rate in Retroviral Vectors Business (2019-2024)
Figure 58. Avid Bioservices, Inc. Revenue Growth Rate in Retroviral Vectors Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Multi-Channel Temperature Controllers Market Research Report 2025
Mar 14, 25
Global Waterproof Action Cameras Market Research Report 2025
Mar 14, 25
Global Infrared IP Cameras Market Research Report 2025
Mar 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232